Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/09/057792
CTRI/2023/09/057792
Not yet recruiting
Phase 4

Comparison of effectiveness of two different dose of dexmedetomidine with ketamine-propofol combination for haemodynamic changes,seizure duration and recovery profile in patients undergoing modified electroconvulsive therapy: A randomised double-blind control study. - NI

Rabindranath Tagore Medical College0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: F333- Major depressive disorder, recurrent, severe with psychotic symptomsHealth Condition 2: O- Medical and SurgicalHealth Condition 3: F54- Psychological and behavioral factors associated with disorders or diseases classified elsewhereHealth Condition 4: F203- Undifferentiated schizophrenia

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: F333- Major depressive disorder, recurrent, severe with psychotic symptomsHealth Condition 2: O- Medical and SurgicalHealth Condition 3: F54- Psychological and behavioral factors associated with disorders or diseases classified elsewhereHealth Condition 4: F203- Undifferentiated schizophrenia
Sponsor
Rabindranath Tagore Medical College
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Rabindranath Tagore Medical College

Eligibility Criteria

Inclusion Criteria

  • •ASA grade I and II having
  • •major depressive disorder (suicidal patients), schizophrenia, catatonia
  • •(in which first line treatment failed) were included who required MECT

Exclusion Criteria

  • •Patients with ASA PS III and above
  • •Patients with history of allergy to study drugs
  • •Pregnant females
  • •Patients with respiratory, cardiovascular, hepatic, cerebrovascular and renal disease
  • •Patients with intracranial hypertension, arterial aneurysm, cerebrovascular malformation etc.
  • •Patients with glaucoma
  • •Patients with history of seizure disorder
  • •Patients with pacemaker

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Comparison of effectiveness of two different doses of nebulised dexmedetomidine with lignocaine for awake fibreoptic intubation.
CTRI/2023/10/059186Rabindranath Tagore Medical College
Not yet recruiting
Phase 4
Clinical trial to Compare the efficacy of two different doses of sugammadex for reversal of vecuronium induced neuromuscular blockage in patients posted for elective surgeries under general anesthesiaHealth Condition 1: 8- Other Procedures
CTRI/2024/08/071853GOVERNMENT MEDICAL COLLEGE BHAVNAGAR
Not yet recruiting
Phase 1
To study the effect of two different doses of oral melatonin on post-operative cognitive dysfunction in elderly patients after surgery under regional anesthesiaHealth Condition 1: G968- Other specified disorders of central nervous system
CTRI/2021/08/035467Department of Anesthesiology
Completed
Phase 3
The effects of two different doses dexmedetomidine after Endotracheal intubatio
IRCT20160307026950N15Esfahan University of Medical Sciences90
Active, not recruiting
Phase 3
Comparison of the efficacy of two dosing regimens of Vitamin D for bone protection in children with difficult nephrotic syndromeHealth Condition 1: null- having nephrotic syndrome
CTRI/2016/10/007405JIPMER60